0
(Adds details in paragraphs 2 to 4) Nov 18 (Reuters) – The US Food and Drug Administration has approved Regeneron Pharmaceuticals' drug to treat adults with a type of rare autoimmune disease called
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)